7th Apr 2021 09:19
(Alliance News) - The European Medicines Agency will hold a press conference on its findings over possible links between AstraZeneca PLC's coronavirus vaccine and blood clots at 1500 BST on Wednesday, the Amsterdam-based regulator said.
"EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Vaxzevria (formerly Covid-19 Vaccine AstraZeneca) relating to cases of thromboembolic events by EMA's safety committee," the watchdog said in a statement.
AstraZeneca shares were down 0.7% at 7,130.52 pence in London on Wednesday
source: AFP
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Astrazeneca